The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...
Vertex also announced enrollment completion of the IA cohort of AMPLITUDE, a global Phase 2/3 clinical trial designed to assess the impact of ...
Firaxis and 2K continue to twiddle with Civilization 7's exploration phase, adding new map generators that produce more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback